Healthcare provider profile · identity verified

Iris Boettcher, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · BYRON CENTER, MI · NPI 1003863226

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Iris Boettcher, MD received $30.23 in general payments during 2025 across 1 reported records.

Otsuka Pharmaceutical Development & Commercialization, Inc. accounted for 100.0% of that reported general-payment amount.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$30.23

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Otsuka Pharmaceutical Development & Commercialization, Inc.	Unresolved — no canonical attribution shown	$30.23	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$30.23	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	363	82
Amlodipine Besylate	Amlodipine Besylate	256	53
Levothyroxine Sodium	Levothyroxine Sodium	230	62
Metoprolol Succinate	Metoprolol Succinate	194	47
Lisinopril	Lisinopril	187	43
Furosemide	Furosemide	177	41
Omeprazole	Omeprazole	172	43
Losartan Potassium	Losartan Potassium	150	35
Pantoprazole Sodium	Pantoprazole Sodium	149	32
Sertraline Hcl	Sertraline Hcl	149	33
Citalopram Hbr	Citalopram Hydrobromide	146	34
Eliquis	Apixaban	137	28
Duloxetine Hcl	Duloxetine Hcl	121	24
Trazodone Hcl	Trazodone Hcl	121	30
Metformin Hcl	Metformin Hcl	115	22
Donepezil Hcl	Donepezil Hcl	108	25
Carvedilol	Carvedilol	92	21
Warfarin Sodium	Warfarin Sodium	90	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	88	18
Escitalopram Oxalate	Escitalopram Oxalate	87	24
Quetiapine Fumarate	Quetiapine Fumarate	86	20
Clopidogrel	Clopidogrel Bisulfate	82	14
Tamsulosin Hcl	Tamsulosin Hcl	82	20
Potassium Chloride	Potassium Chloride	80	21
Memantine Hcl	Memantine Hcl	77	20
Mirtazapine	Mirtazapine	77	19
Alendronate Sodium	Alendronate Sodium	70	12
Fluoxetine Hcl	Fluoxetine Hcl	70	14
Risperidone	Risperidone	69	16
Gabapentin	Gabapentin	67	28
Allopurinol	Allopurinol	55	13
Bupropion Xl	Bupropion Hcl	47	14
Rosuvastatin Calcium	Rosuvastatin Calcium	44	11
Levetiracetam	Levetiracetam	43	suppressed
Baclofen	Baclofen	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	16
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Famotidine	Famotidine	40	13
Montelukast Sodium	Montelukast Sodium	39	suppressed
Olanzapine	Olanzapine	39	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	14
Finasteride	Finasteride	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	36	suppressed
Simvastatin	Simvastatin	36	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Prednisone	Prednisone	34	suppressed
Divalproex Sodium	Divalproex Sodium	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Torsemide	Torsemide	33	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Brilinta	Ticagrelor	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Jardiance	Empagliflozin	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	27	14
Cephalexin	Cephalexin	27	16
Lovastatin	Lovastatin	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Celecoxib	Celecoxib	23	suppressed
Valsartan	Valsartan	23	suppressed
Verapamil Sr	Verapamil Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	22	suppressed
Nystatin	Nystatin	21	suppressed
Atenolol	Atenolol	20	suppressed
Dulera	Mometasone/Formoterol	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Primidone	Primidone	20	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Topiramate	Topiramate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Memantine Hcl Er	Memantine Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Auryxia	Ferric Citrate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Linzess	Linaclotide	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Neupro	Rotigotine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$30.23 · 1 records	Otsuka Pharmaceutical Development & Commercialization, Inc.	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error